You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Drug Therapy, Other

Citations 71-80 of 113 total displayed.

Past content (since Sep 1999):

Correspondence
Antihypertensive Medications Influence the Rate of Conversion From Mild Cognitive Impairment to Alzheimer Disease—Reply
Christiane Reitz; Richard Mayeux; José A. Luchsinger
Arch Neurol 2008; 65: 995. [Extract] [Full text]  

Original Contributions
Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Chitra Krishnan; Adam I. Kaplin; Robert A. Brodsky; Daniel B. Drachman; Richard J. Jones; Dzung L. Pham; Nancy D. Richert; Carlos A. Pardo; David M. Yousem; Edward Hammond; Megan Quigg; Carrilin Trecker; Justin C. McArthur; Avindra Nath; Benjamin M. Greenberg; Peter A. Calabresi; Douglas A. Kerr
Arch Neurol 65.8.noc80042. [Abstract] [Full text] []  

Neurological Reviews
Common Pathophysiologic Mechanisms in Migraine and Epilepsy
Michael A. Rogawski
Arch Neurol 2008; 65: 709-714. [Abstract] [Full text] [PDF]  

Original Contributions
Induced Neuroprotection Independently From PrPSc Accumulation in a Mouse Model for Prion Disease Treated With Simvastatin
Yaron Haviv; Dana Avrahami; Haim Ovadia; Tamir Ben-Hur; Ruth Gabizon; Ronit Sharon
Arch Neurol 2008; 65: 762-775. [Abstract] [Full text] [PDF]  

Original Contributions
Effect of Oral Sucrose Shortly Before Exercise on Work Capacity in McArdle Disease
Susanne Tvede Andersen; Ronald G. Haller; John Vissing
Arch Neurol 2008; 65: 786-789. [Abstract] [Full text] [PDF]  

Clinical Trials
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib
ADAPT Research Group
Arch Neurol 2008.65.7.nct70006. [Abstract] [Full text] []  

Clinical Trials
Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients With Advanced Parkinson Disease and Motor Fluctuations: The ADVANS Study
Olivier Rascol; Werner Poewe; Andrew Lees; Marina Aristin; Laurence Salin; Nolwenn Juhel; Lisa Waldhauser; Thomas Schindler; for the ADVANS Study Group
Arch Neurol 2008; 65: 577-583. [Abstract] [Full text] [PDF]  

Observations
Lymphomatoid Granulomatosis Involving Central Nervous System Successfully Treated With Rituximab Alone
Hiroyuki Ishiura; Masato Morikawa; Masashi Hamada; Takuro Watanabe; Shinichi Kako; Shigeru Chiba; Toru Motokura; Akira Hangaishi; Junji Shibahara; Masaaki Akahane; Jun Goto; Shin Kwak; Mineo Kurokawa; Shoji Tsuji
Arch Neurol 2008; 65: 662-665. [Abstract] [Full text] [PDF]  

Images in Neurology
Successful Treatment of Histoplasmosis Brain Abscess With Voriconazole
Jayashri Srinivasan; Winnie W. Ooi
Arch Neurol 2008; 65: 666-667. [Extract] [Full text] [PDF]  

Research Letters
Atorvastatin Does Not Alter Interferon Beta–Induced Changes of Serum Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 in Patients With Multiple Sclerosis
Johann Sellner; Isabell Greeve; Stephen L. Leib; Heinrich P. Mattle
Arch Neurol 2008; 65: 672-674. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 • Show Drug Therapy, Other
 collections from JAMA & Archives Journals.
 •Related collections:
  •Drug Therapy
  •Adherence
  •Adverse Effects
  •Medication Error
  •Pediatric Dosing
  •Drug Therapy, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.